.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

OncClub: Join the Chat on Trending Trials in Cancer
Final results from the Phase 3 ClarIDHy trial
Lively expert panel discussions featuring peer-to-peer exchanges
Long-term efficacy and safety of TRK fusion-positive lung cancer treatment

SpecialtySee All >

Biosimilars
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Head & Neck Cancers
Hematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Multiple Myeloma

Advertise
About OncLive
Editorial Board
CureToday.com
TargetedOnc.com
CancerNetwork.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

Navigating New Treatment Options for Advanced HCC

EP. 1: Genetic Profiling in HCC

February 18th 2019

EP. 2: Assessing Liver Function & Actionable Mutations in HCC

February 18th 2019

EP. 3: Treatment Options for Locally Advanced HCC

February 18th 2019

EP. 4: Evolution of Systemic Therapy in HCC

February 18th 2019

EP. 5: ASCO GI 2019 Update: REFLECT Study

February 18th 2019

EP. 6: Optimizing Sequencing of Therapies in HCC

February 18th 2019

EP. 7: Comparative Data in Available TKIs for HCC

February 18th 2019

EP. 8: Two Options for Checkpoint Inhibition in HCC

February 18th 2019

EP. 9: Anticipating Results of Checkpoint Inhibitors in HCC

February 18th 2019

EP. 10: Durable Activity in Synergistic Combination for HCC

February 18th 2019

EP. 11: Understanding How Best to Sequence in Advanced HCC

February 18th 2019

EP. 12: Advanced HCC: What's Next?

February 18th 2019